MOH authorizes use of Bamlanivimab to treat mild to moderate cases of COVID

KUWAIT CITY, Dec 1: Kuwait’s Ministry of Health (MoH) authorized the drug “Bamlanivimab” for emergency use to treat mild to moderate cases of COVID-19 in adult patients and kids over 12 years old who have risk factors that make them more vulnerable.

Assistant Undersecretary for Drug and Food Control Affairs Dr Abdullah Al- Bader said, in a press statement on Tuesday, that the last emergency use of Baricitinib was licensed to be used as an added drug to Remdesivir to treat COVID-19 cases in adult patients and children over two years old who are receiving hospital treatment with ventilators. (KUNA)

The post MOH authorizes use of Bamlanivimab to treat mild to moderate cases of COVID appeared first on ARAB TIMES – KUWAIT NEWS.

Leave a Reply

Your email address will not be published. Required fields are marked *